DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)

CNY 17.14

(-1.49%)

Market Cap (In CNY)

19.48 Billion

Revenue (In CNY)

24.43 Billion

Net Income (In CNY)

1.16 Billion

Avg. Volume

8.28 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
11.92-27.1
PE
22.85
EPS
0.75
Beta Value
0.338
ISIN
CNE100002RG2
CUSIP
-
CIK
-
Shares
1136531734.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Guoqiang Ke
Employee Count
-
Website
https://www.dslyy.com
Ipo Date
2017-07-31
Details
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. The company was founded in 1999 and is based in Guangzhou, China.